CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Zota Health Care Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Zota Health Care Ltd
"Zota House"
2/896, Hira Modi Street Sagrampura
Phone: +91 2612331601p:+91 2612331601 SURAT, 395002  India Ticker: ZOTAZOTA
Business Summary
Zota Health Care Limited is an India-based pharmaceutical company, which is engaged in manufacturing and marketing of pharmaceutical products catering to domestic and international markets. It engages in manufacturing, marketing, and exporting a range of pharmaceutical, ayurvedic, nutraceutical, and over the counter (OTC) products. The Company’s business model comprises three verticals, namely Domestic, Exports and Retail Pharmacy Chain. Its Marketing business vertical involves the direct distribution of generic drugs, OTC products, and other pharmaceutical products. Its products span across approximately 24 divisions, with a portfolio of over 4,000 therapeutic product categories such as generics, OTC products, allopathic, ayurvedic, and others. Its Retail Pharmacy Chain business vertical operates a chain of approximately 594 pharmacy stores under the brand Davaindia. Its Domestic products include AZIVAR-100 DT Tab, AZIVAR-250 Tab, AZIVAR-500 Tab, AZIVAR-CX Tab, among others.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/20243/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Board Ketankumar C.Zota 56 10/1/2010 10/1/2010
Chief Financial Officer Viral A.Mandviwala
Compliance Officer, Company Secretary Ashvin B.Variya
11 additional Officers and Directors records available in full report.

General Information
Number of Employees: 445 (As of 3/31/2024)
Outstanding Shares: 26,534,327 (As of 5/7/2024)
Shareholders: 7,594
Stock Exchange: NSE


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024